Purdue Pharma was sentenced Tuesday to $5.5 billion in fines and penalties on charges of deceiving regulators and paying doctors to boost opioid sales.

OxyContin maker Purdue Pharma has been ordered to pay $225 million in a criminal case related to how it sold its blockbuster opioid painkiller.

Purdue Pharma was sentenced Tuesday to $5.5 billion in fines and penalties on charges of deceiving regulators and paying doctors to boost opioid sales.

A federal judge on Tuesday sentenced Purdue Pharma to pay more than $5 billion in criminal penalties, clearing the way for its bankruptcy settlement.

OxyContin maker to be replaced by new company aiming to combat opioid crisis as legal settlement takes effect